RBC Capital Sticks to Its Hold Rating for Clorox (CLX)
In a report released today, Nik Modi from RBC Capital maintained a Hold rating on Clorox, with a price target of $132.00.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
According to TipRanks, Modi is an analyst with an average return of -4.6% and a 41.20% success rate. Modi covers the Consumer Defensive sector, focusing on stocks such as Kimberly Clark, Primo Brands, and Colgate-Palmolive.
In addition to RBC Capital, Clorox also received a Hold from TipRanks – Google’s Google Household and Personal Products in a report issued today. However, on the same day, Barclays maintained a Sell rating on Clorox (NYSE: CLX).
Based on Clorox’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $1.43 billion and a net profit of $80 million. In comparison, last year the company earned a revenue of $1.76 billion and had a net profit of $99 million
Based on the recent corporate insider activity of 51 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of CLX in relation to earlier this year. Most recently, in November 2025, Pierre Breber, a Director at CLX bought 4,000.00 shares for a total of $416,480.00.
Read More on CLX:
